Amphastar Pharmaceuticals, Inc. (AMPH) financial statements (2021 and earlier)

Company profile

Business Address 11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1069998678598123
Cash and cash equivalents938887557486120
Short-term investments1311111212133
Restricted cash and investments4442444
Receivables66525058454549
Inventory, net of allowances, customer advances and progress billings9710910510811111099
Inventory9710910510811111099
Other undisclosed current assets712101210119
Total current assets:280277267247255269284
Noncurrent Assets
Finance lease, right-of-use asset11111  
Operating lease, right-of-use asset2020171819  
Property, plant and equipment260246238231234222220
Intangible assets, net (including goodwill), including:41404040414142
Goodwill4444444
Intangible assets, net (excluding goodwill)37778889
Other undisclosed intangible assets, net (including goodwill)0292929292929
Deferred income tax assets2522242426  
Other noncurrent assets581311111214
Deferred tax assets, net2121
Other undisclosed noncurrent assets     2021
Total noncurrent assets:352337333326332317317
TOTAL ASSETS:631614600573587586601
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities96797565777588
Accounts payable24232217252231
Accrued liabilities71565449525357
Debt12121211877
Other undisclosed current liabilities4566546
Total current liabilities:1129793839087101
Noncurrent Liabilities
Long-term debt and lease obligation, including:34333536393840
Long-term debt, excluding current maturities46   46  
Operating lease, liability1718151516  
Other undisclosed long-term debt and lease obligation(29)152021(23)3840
Liabilities, other than long-term debt19161514141010
Accounts payable and accrued liabilities5333300
Deferred tax liabilities, net11
Deferred income tax liabilities11111  
Other liabilities13111110999
Other undisclosed noncurrent liabilities17181515161718
Total noncurrent liabilities:70666466696568
Total liabilities:183163158149159152169
Stockholders' equity
Stockholders' equity attributable to parent402405398378381389388
Common stock0000000
Treasury stock, value(122)(118)(114)(108)(98)(84)(79)
Additional paid in capital410404397371367362355
Accumulated other comprehensive loss(4)(4)(5)(5)(5)(6)(4)
Retained earnings118124120120116117116
Stockholders' equity attributable to noncontrolling interest46464546464444
Total stockholders' equity:449451442423428434432
TOTAL LIABILITIES AND EQUITY:631614600573587586601

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues96838685838079
Cost of revenue(59)(47)(53)(48)(50)(45)(47)
Cost of goods and services sold(1)(3)(8)(2)(3)(0)(3)
Gross profit:37373337333532
Operating expenses(34)(33)(36)(29)(34)(33)(31)
Operating income (loss):34(3)7(0)21
Nonoperating income (expense)(10)41(2)1(1)60
Investment income, nonoperating0000000
Other nonoperating income (expense)(10)41(2)1(1)60
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(7)7(2)61261
Other undisclosed income from continuing operations before income taxes0000000
Income (loss) from continuing operations before income taxes:(7)7(2)61261
Income tax expense (benefit)1(2)0(2)(0)(1)(14)
Net income (loss):(6)5(1)41147
Net income (loss) attributable to noncontrolling interest(0)(1)10(2)01
Net income (loss) available to common stockholders, diluted:(6)4(0)4(1)148

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(6)5(1)41147
Comprehensive income (loss):(6)5(1)41147
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)(1)10(2)01
Other undisclosed comprehensive income (loss), net of tax, attributable to parent110(1)1(2)(0)
Comprehensive income (loss), net of tax, attributable to parent:(6)5030(0)48

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: